Grazyna Bober
Katowice, SL 40032, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
High Level of CD8+PD-1+ Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib Discontinuation.
Journal: Cells
Published: March 29, 2024
The Outcomes of Ponatinib Therapy in Patients With Chronic Myeloid Leukemia Resistant or Intolerant to Previous Tyrosine Kinase Inhibitors, Treated in Poland Within the Donation Program.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 06, 2021
Ear involvement in acute promyelocytic leukemia.
Journal: Polish archives of internal medicine
Published: July 07, 2017
A multicenter prospective study on efficacy and safety of imatinib generics: A report from Polish Adult Leukemia Group imatinib generics registry.
Journal: American journal of hematology
Published: March 09, 2017
Quality of Life and Adherence to Therapy in Patients With Chronic Myeloid Leukemia Treated With Nilotinib as a Second-Line Therapy: A Multicenter Prospective Observational Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: December 23, 2016
Occurrence of secondary malignancies in chronic myeloid leukemia during therapy with imatinib mesylate-single institution experience.
Journal: Mediterranean journal of hematology and infectious diseases
Published: August 20, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026